Zealand Pharma A/S at Barclays Global Healthcare Conference Transcript
Hey. Good afternoon, everyone. I'm Yihan Li, Barclays European Biopharma after research analyst. Today, it is my pleasure to host Zealand Pharma, a fire chat with Adam Steensberg, the CEO of Zealand.
So thank you for joining us today, and we are delighted to have you here to walk us through your story. So actually, to start it, I will hand it over to you, Adam, to have a brief introduction of Zealand and do some presentation.
/- -
Absolutely a pleasure to be here. So Zealand Pharma, we are here to address what we believe is the biggest health care challenge of our time and that's the obesity pandemic and all the diseases that follows the obesity pandemic, you can actually ascribe more than 220 diseases to the increase in obesity that we see these years. And we need to do something about this as a society. So transforming the future of metabolic health, that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

